Comparison of distal minimally invasive metatarsal osteotomy and open chevron osteotomy in the treatment of hallux valgus (HV): A network meta-analysis.

J Foot Ankle SurgMay 14, 2026 (epub)
Clinical ResearchOrthopedic Surgery

Congqiang Rao, Xiaolian Lu, Binggang Xiong et al.

✦ AI-curated · Sources linked

In 30 seconds

This network meta-analysis compared the effectiveness of distal minimally invasive metatarsal osteotomy and open chevron osteotomy for treating hallux valgus in 842 patients. Results indicated that minimally invasive transverse osteotomy significantly improved the hallux valgus angle (HVA) by -1.5 degrees and the intermetatarsal angle (IMA) by -0.76 degrees compared to open chevron osteotomy.

Key findings

  • Minimally invasive transverse osteotomy improved HVA by -1.5 degrees (95% CI: -2.5, -0.39).
  • Minimally invasive transverse osteotomy improved IMA by -0.76 degrees (95% CI: -1.3, -0.20).
  • Minimally invasive chevron osteotomy improved DMAA by -5.8 degrees (95% CI: -8 to -3.7).
  • Minimally invasive chevron osteotomy ranked highest for AOFAS score (SUCRA=81.53%).

Why it matters

Understanding the comparative effectiveness of surgical techniques for hallux valgus can guide clinicians in selecting appropriate interventions, potentially leading to better patient outcomes in terms of both radiographic correction and functional improvement.

Source

PubMed · PMID 42134765

Published in J Foot Ankle Surg. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Orthopedic Surgery

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.